- Regulatory Status
- RUO
- Other Names
- Leukemia inhibitory factor, HILDA (human interleukin in DA cells), MLPLI (melanoma-derived LPL inhibitor), DIA (differentiation-inducing factor), MCP1
| Cat # | Size | Price | Quantity Check Availability | ||
|---|---|---|---|---|---|
| 716504 | 20 µg | $253.00 | |||
This product is not available for shipping outside of the United States.
Select size of product is eligible for a 40% discount! Promotion valid until December 31, 2024. Exclusions apply. To view full promotion terms and conditions or to contact your local BioLegend representative to receive a quote, visit our webpage.
CCL2, also known as MCP-1, is a member of the CC β chemokine family. It is widely expressed in endothelial cells, smooth muscle cells, and monocytes in response to several atherogenic stimulants such as CD40 ligand, platelet derived growth factor (PDGF), interleukin-1β (IL-1β) and oxidized low density lipoprotein. Several recent in vivo studies have disclosed critical roles of MCP-1 in atherosclerosis. In addition, MCP-1 has been implicated in monocytic infiltration of tissues during several inflammatory diseases and has been implicated in macrophage-mediated tumor growth suppression in mice. CCL2 has been shown to have direct effects on tumor cells in an autocrine and paracrine fashion in multiple cancer types, including breast, lung, cervix, ovary, sarcoma, and prostate. In addition, MCP-1 plays a key role in the regulation of MMPs during transmigration. MCP-1 has been described as a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Kidney epithelial cells, including glomerular podocytes and tubular cells make MCP-1 in response to high glucose and advanced glycation end products. MCP-1 promotes inflammation and progressive injury in diabetic kidneys. The importance of MCP-1 in the early development of diabetic nephropathy has been determined in animal models incorporating genetically deficient mice or therapeutic blockade of MCP-1 receptor (CCR2).
Product Details
- Source
- Human CCL2, amino acids Gln24-Thr99 (NM_002982), was expressed in E.coli.
- Molecular Mass
- The 76 amino acid recombinant protein has a predicted molecular mass of 8.7 kD. The predicted N-terminal amino acid is Gln.
- Purity
- >98%, as determined by Coomassie stained SDS-PAGE and HPLC analysis.
- Formulation
- Lyophilized, carrier-free.
- Endotoxin Level
- Less than 0.1 ng per µg of protein.
- Storage & Handling
- Unopened vial can be stored at -20°C or -70°C. For maximum results, quick spin vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. It is recommended to further dilute in a buffer, such as 5% Trehalose, and store working aliquots at -20°C to -80°C. Avoid repeated freeze/thaw cycles.
- Activity
- Determined by its ability to chemoattract human monocytes using a concentration range of 10 - 100 ng/ml.
- Application
-
Bioassay
- Application Notes
-
This product is reactive with human, bacteria, chicken, monkey, mouse, and rat.
Antigen Details
- Structure
- Chemokine
- Distribution
- CCL2 (MCP-1) is secreted by fibroblast, endothelial cells, smooth muscle cells, tumor cells, phytohemaglutinin stimulated mononuclear cells.
- Function
- Monocyte chemotactic and activating factor (MCAF), monocyte secretory protein JE, small inducible cytokine A2 (SCYA2).
- Ligand/Receptor
- CCL2 mediates its cellular effects primarily through CCR2 receptor.
- Cell Type
- Hematopoietic stem and progenitors
- Biology Area
- Cell Biology, Neuroinflammation, Neuroscience, Stem Cells
- Molecular Family
- Cytokines/Chemokines
- Antigen References
-
1. Loberg RD, et al. 2007. Cancer Research. 67:9417.
2. Gregory JL, et al. 2006. J. Immunol. 177:8072.
3. Qui Z, et al. 2009. Immunology. 214:835.
4. Reichel CA, et al. 2009. Arterioscler. Thromb. Vasc. Biol. ATVBAHA.109.193268v1
5. McQuibban GA, et al. 2002. Blood 100:1160.
5. Tesh GH, et al. 2008. Amm. J. Physiol. Renal. Physiol. 294:F697-F701. - Gene ID
- 6347 View all products for this Gene ID
- UniProt
- View information about CCL2 on UniProt.org